-
1 Comment
LBX Pharmacy Chain Joint Stock Company is currently in a long term downtrend where the price is trading 25.7% below its 200 day moving average.
From a valuation standpoint, the stock is 78.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.1.
LBX Pharmacy Chain Joint Stock Company's total revenue rose by 21.0% to $3B since the same quarter in the previous year.
Its net income has increased by 21.9% to $151M since the same quarter in the previous year.
Finally, its free cash flow grew by 124.5% to $450M since the same quarter in the previous year.
Based on the above factors, LBX Pharmacy Chain Joint Stock Company gets an overall score of 4/5.
| CurrencyCode | CNY |
|---|---|
| Exchange | SHG |
| ISIN | CNE1000023Q8 |
| Sector | Healthcare |
| Industry | Pharmaceutical Retailers |
| PE Ratio | 17.17 |
|---|---|
| Target Price | 28.21 |
| Market Cap | 14B |
| Beta | 0.71 |
| Dividend Yield | None |
LBX Pharmacy Chain Joint Stock Company operates pharmacy store chain in China. The company was formerly known as Laobaixing Pharmacy Chain Joint Stock Company. LBX Pharmacy Chain Joint Stock Company was founded in 2001 and is based in Changsha, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 603883.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
